These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. From the monovalent to the nine-valent HPV vaccine. Pils S; Joura EA Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355 [TBL] [Abstract][Full Text] [Related]
5. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and incidence of HPV genital infection in women. Velicer C; Zhu X; Vuocolo S; Liaw KL; Saah A Sex Transm Dis; 2009 Nov; 36(11):696-703. PubMed ID: 19652630 [TBL] [Abstract][Full Text] [Related]
7. Introducing human papillomavirus vaccines - questions remain. Paavonen J; Lehtinen M Ann Med; 2008; 40(3):162-6. PubMed ID: 18382882 [TBL] [Abstract][Full Text] [Related]
8. Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review. Maver PJ; Poljak M Vaccine; 2018 Aug; 36(36):5416-5423. PubMed ID: 28801154 [TBL] [Abstract][Full Text] [Related]
9. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Malagón T; Drolet M; Boily MC; Franco EL; Jit M; Brisson J; Brisson M Lancet Infect Dis; 2012 Oct; 12(10):781-9. PubMed ID: 22920953 [TBL] [Abstract][Full Text] [Related]